<!--HTML document created with Certent Disclosure Management 6.5.1.4-->
<!--Created on: 1/27/2017 12:50:06 PM-->
<html>
	<head>
		<title>
			8K 2017-01-27
		</title>
	</head>
	<body><div style="margin-left:72pt;margin-right:72pt;">
		<p style="margin:0.5pt 36pt 0pt 36.5pt;border-bottom:1pt solid #000000 ;line-height:100%;font-family:Calibri;font-size: 12pt">
			<a name="_GoBack"></a><font style="display: inline;font-family:Times New Roman;font-size:12pt;">&#xFEFF;</font>
		</p>
		<p style="margin:3pt 36pt 0pt 39pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 18pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:18pt;">UNITED STATES</font>
		</p>
		<p style="margin:0pt 36pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 18pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:18pt;">SECURITIES AND EXCHANGE COMMISSION</font>
		</p>
		<p style="margin:0pt 36pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">Washington, DC 20549</font>
		</p>
		<p style="margin:0pt 36pt;line-height:100%;font-family:Calibri;font-size: 5pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 263.4pt;border-bottom:1pt solid #000000 ;line-height:100%;text-align:center;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:18pt 36pt 0pt 54pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 18pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:18pt;">FORM 8-K</font>
		</p>
		<p style="margin:0pt 36pt;line-height:100%;font-family:Calibri;font-size: 5pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 263.4pt;border-bottom:1pt solid #000000 ;line-height:100%;text-align:center;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:4.5pt 36pt 0pt 40.5pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 13pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:13.5pt;">CURRENT REPORT</font>
		</p>
		<p style="margin:9pt 36pt 0pt 45pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">Pursuant to Section&nbsp;13 or 15(d) of</font>
		</p>
		<p style="margin:0pt 36pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">The Securities Exchange Act of 1934</font>
		</p>
		<p style="margin:9pt 36pt 0pt 45pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">Date of Report (Date of earliest event reported)</font>
		</p>
		<p style="margin:9pt 36pt 0pt 45pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">January 25, 2017</font>
		</p>
		<p style="margin:0pt 36pt;line-height:100%;font-family:Calibri;font-size: 5pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 263.4pt;border-bottom:1pt solid #000000 ;line-height:100%;text-align:center;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:4.5pt 36pt 0pt 40.5pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 24pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:24pt;">Pulse Biosciences, Inc.</font>
		</p>
		<p style="margin:0pt 36pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">(Exact name of registrant as specified in its charter)</font>
		</p>
		<p style="margin:0pt 36pt;line-height:100%;font-family:Calibri;font-size: 5pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 263.4pt;border-bottom:1pt solid #000000 ;line-height:100%;text-align:center;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:2.5pt 36pt 0pt 38.5pt;line-height:100%;font-family:Calibri;font-size: 5pt">
			<font style="display: inline;">&nbsp;</font><a name="FIS_UNIDENTIFIED_TABLE"></a>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;margin-left:0pt;">
			<tr>
				<td valign="middle" style="width:175.10pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;height:1.00pt;overflow:hidden;font-size: 1pt">
						<font style="display: inline;font-size:1pt;">&#xFEFF;</font></p>
				</td>
				<td valign="bottom" style="width:07.45pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="middle" style="width:176.85pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="middle" style="width:173.20pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:175.10pt;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 9pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:07.45pt;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 9pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="middle" style="width:176.85pt;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 9pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:07.40pt;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 9pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="middle" style="width:173.20pt;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 9pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:175.10pt;padding:0pt;">
					<p style="margin:0pt 1.55pt 0pt 0pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 9pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:9.5pt;">Nevada</font></p>
				</td>
				<td valign="bottom" style="width:07.45pt;padding:0pt;">
					<p style="margin:0pt 1.55pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 6pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:176.85pt;padding:0pt;">
					<p style="margin:0pt 1.55pt 0pt 0pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 9pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:9.5pt;">001-37744</font></p>
				</td>
				<td valign="bottom" style="width:07.40pt;padding:0pt;">
					<p style="margin:0pt 1.55pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 6pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:173.20pt;padding:0pt;">
					<p style="margin:0pt 1.55pt 0pt 0pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 9pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:9.5pt;">46-5696597</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:175.10pt;padding:0pt;">
					<p style="margin:0pt 1.55pt 0pt 0pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 7pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:7pt;">(State or other jurisdiction</font></p>
					<p style="margin:0pt 1.55pt 0pt 0pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 7pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:7pt;">of incorporation)</font></p>
				</td>
				<td valign="bottom" style="width:07.45pt;padding:0pt;">
					<p style="margin:0pt 1.55pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 6pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:176.85pt;padding:0pt;">
					<p style="margin:0pt 1.55pt 0pt 0pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 7pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:7pt;">(Commission</font></p>
					<p style="margin:0pt 1.55pt 0pt 0pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 7pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:7pt;">File Number)</font></p>
				</td>
				<td valign="bottom" style="width:07.40pt;padding:0pt;">
					<p style="margin:0pt 1.55pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 6pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:173.20pt;padding:0pt;">
					<p style="margin:0pt 1.55pt 0pt 0pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 7pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:7pt;">(IRS Employer</font></p>
					<p style="margin:0pt 1.55pt 0pt 0pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 7pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:7pt;">Identification No.)</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:9pt 36pt 0pt 45pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">849 Mitten Road, Suite 104</font>
		</p>
		<p style="margin:0pt 36pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">Burlingame, California 94010</font>
		</p>
		<p style="margin:0pt 36pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 7pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:7.5pt;">(Address of principal executive offices, including zip code)</font>
		</p>
		<p style="margin:9pt 36pt 0pt 45pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">(650) 697-3939</font>
		</p>
		<p style="margin:0pt 36pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 7pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:7.5pt;">(Registrant&#x2019;s telephone number, including area code)</font>
		</p>
		<p style="margin:0pt 36pt;line-height:100%;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:18pt 36pt 0pt 54pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 7pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:7.5pt;">(Former name or former address, if changed since last report)</font>
		</p>
		<p style="margin:0pt 36pt;line-height:100%;font-family:Calibri;font-size: 5pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 263.4pt;border-bottom:1pt solid #000000 ;line-height:100%;text-align:center;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:1pt 36pt 0pt;line-height:100%;font-family:Calibri;font-size: 8pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:4.5pt 36pt 0pt 40.5pt;line-height:100%;font-family:Calibri;font-size: 10pt">
			<br /><font style="display: inline;font-family:Times New Roman;font-size:10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2):</font>
		</p>
		<p style="margin:0pt 36pt;line-height:100%;font-family:Calibri;font-size: 5pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;margin-left:0pt;">
			<tr>
				<td valign="top" style="width:21.50pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;height:1.00pt;overflow:hidden;font-size: 1pt">
						<font style="display: inline;font-size:1pt;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="width:482.50pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:21.50pt;padding:0pt;">
					<p style="margin:0pt 1.6pt 0pt 0pt;font-family:Calibri;line-height:107.92%;font-size: 12pt">
						<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="width:482.50pt;padding:0pt;">
					<p style="margin:0pt 1.6pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-size:10pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt 36pt;line-height:100%;font-family:Calibri;font-size: 1pt">
			<font style="display: inline;font-family:Times New Roman;font-size:1pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 36pt;line-height:100%;font-family:Calibri;font-size: 5pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;margin-left:0pt;">
			<tr>
				<td valign="top" style="width:21.65pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;height:1.00pt;overflow:hidden;font-size: 1pt">
						<font style="display: inline;font-size:1pt;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="width:482.35pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:21.65pt;padding:0pt;">
					<p style="margin:0pt 1.6pt 0pt 0pt;font-family:Calibri;line-height:107.92%;font-size: 12pt">
						<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="width:482.35pt;padding:0pt;">
					<p style="margin:0pt 1.6pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-size:10pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt 36pt;line-height:100%;font-family:Calibri;font-size: 1pt">
			<font style="display: inline;font-family:Times New Roman;font-size:1pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 36pt;line-height:100%;font-family:Calibri;font-size: 5pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;margin-left:0pt;">
			<tr>
				<td valign="top" style="width:21.45pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;height:1.00pt;overflow:hidden;font-size: 1pt">
						<font style="display: inline;font-size:1pt;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="width:482.55pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:21.45pt;padding:0pt;">
					<p style="margin:0pt 1.6pt 0pt 0pt;font-family:Calibri;line-height:107.92%;font-size: 12pt">
						<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="width:482.55pt;padding:0pt;">
					<p style="margin:0pt 1.6pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-size:10pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt 36pt;line-height:100%;font-family:Calibri;font-size: 1pt">
			<font style="display: inline;font-family:Times New Roman;font-size:1pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 36pt;line-height:100%;font-family:Calibri;font-size: 5pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;margin-left:0pt;">
			<tr>
				<td valign="top" style="width:21.45pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;height:1.00pt;overflow:hidden;font-size: 1pt">
						<font style="display: inline;font-size:1pt;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="width:482.55pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:21.45pt;padding:0pt;">
					<p style="margin:0pt 1.6pt 0pt 0pt;font-family:Calibri;line-height:107.92%;font-size: 12pt">
						<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="width:482.55pt;padding:0pt;">
					<p style="margin:0pt 1.6pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-size:10pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0.5pt 36pt 0pt 36.5pt;border-bottom:1pt solid #000000 ;line-height:100%;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:9.25pt 36pt 0pt;line-height:100%;font-family:Calibri;font-size: 10pt">
			<a name="FIS_SECTION_1_BUSINESS_AND_OPERATIONS"></a><a name="FIS_ENTRY_MATERIAL_AGREEMENT"></a>
		</p>
		<p><font size="1"> </font></p><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p>
		<p style="margin:9.25pt 36pt 0pt;line-height:100%;font-family:Calibri;;font-size: 10pt"><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">Item&nbsp;1.01&nbsp;Entry into a Material Definitive Agreement. &nbsp;</font>
		</p>
		<p style="margin:0pt 36pt;line-height:100%;text-indent:24.5pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt">
			<a name="PACB_20150724X8K_HTM_T6233038038"></a><font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 36pt;line-height:100%;text-indent:24.5pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-size:10pt;">On January 25, 2017, Pulse Biosciences, Inc. (the &#x201C;Company&#x201D;) entered into a new lease agreement (the &#x201C;Lease&#x201D;) by and between the Company and Hayward Point Eden I Limited Partnership, a Delaware limited liability company (the &#x201C;Landlord&#x201D;), for premises consisting of approximately fifteen thousand six hundred ninety-seven (15,697) rentable square feet located at 3955 Point Eden Way, Hayward, California (the &#x201C;Premises&#x201D;).&nbsp;</font>
		</p>
		<p style="margin:0pt 36pt;line-height:100%;text-indent:24.5pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 36pt;line-height:100%;text-indent:24.5pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-size:10pt;">The Premises will be used for the Company&#x2019;s corporate headquarters and principal operating facility. The term of the Lease is sixty-two (62) months, commencing on the date that is the earlier of (i) the date upon which the Company commences business in the Premises or (ii) the date upon which the Premises is &#x201C;Ready for Occupancy&#x201D; as defined in the lease.&nbsp;&nbsp;Base monthly rent shall be abated for the first two (2) months of the Lease term and thereafter will be $42,400 per month during the first year of the Lease term, with specified annual increases thereafter until reaching approximately $50,300 per month during the last two (2) months of the Lease term. The Company is required to pay a refundable security deposit of approximately $101,000.&nbsp;&nbsp; The Landlord is obligated to provide the Company with improvement allowances in the amount of approximately $135.00 per rentable square foot of the Premises, which may be applied towards the costs of construction of the initial improvements in the Premises. The Company will be responsible for any such improvement costs in excess of the foregoing allowances.&nbsp;&nbsp;The Company may also be required to reimburse Landlord for certain expenses during the Lease term.</font>
		</p>
		<p style="margin:5pt 36pt 0pt;line-height:100%;text-indent:27pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-size:10pt;">The Company has the right to extend the Lease term by five (5) years upon written notice not more than twelve (12) months nor less than nine (9) months prior to the expiration of the original Lease term, with monthly payments equal to the &#x201C;Fair Rental Value&#x201D; as defined in the Lease.&nbsp;&nbsp;The Company has also reserved the right to terminate the Lease if the Landlord is unable to deliver the facility to the Company by December 1, 2017.</font>
		</p>
		<p style="margin:5pt 36pt 0pt;text-align:center;font-family:Calibri;line-height:107.92%;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&#xFEFF;</font>
		</p>
		<p style="margin:11.25pt 36pt 0pt;font-family:Calibri;line-height:107.92%;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&#xFEFF;</font>
		</p>
		<p style="margin:11.25pt 36pt 0pt;line-height:100%;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;">&nbsp;</font><a name="eolPage3"></a>
		</p>
		<p style="margin:0pt 36pt;line-height:100%;text-align:right;font-family:Calibri;font-size: 10pt">

		</p>
		<p><font size="1"> </font></p><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p>
		<p style="margin:0pt 36pt;line-height:100%;text-align:right;font-family:Calibri;;font-size: 10pt"><font style="display: inline;">&nbsp;</font><a name="FIS_SIGNATURES"></a>
		</p>
		<p style="margin:0pt 36pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">SIGNATURES</font>
		</p>
		<p style="margin:0pt 36pt;line-height:100%;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 36pt;line-height:100%;text-indent:24.5pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-size:10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</font>
		</p>
		<p style="margin:0pt 36pt;line-height:100%;text-indent:24.5pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 36pt;line-height:100%;text-indent:24.5pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 36pt;line-height:100%;text-indent:24.5pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:234.35pt;margin-left:0pt;">
			<tr>
				<td valign="middle" style="width:28.90pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;height:1.00pt;overflow:hidden;font-size: 1pt">
						<font style="display: inline;font-size:1pt;">&#xFEFF;</font></p>
				</td>
				<td valign="bottom" style="width:07.45pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="middle" style="width:198.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:28.90pt;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:07.45pt;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="middle" style="width:198.00pt;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:28.90pt;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:07.45pt;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="middle" style="width:198.00pt;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td colspan="3" valign="top" style="width:234.35pt;padding:0pt;">
					<p style="margin:0pt 5.6pt 0pt 0pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">Pulse Biosciences, Inc.</font></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:28.90pt;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="middle" style="width:205.45pt;padding:0pt;">
					<p style="margin:0pt 1.8pt 0pt 0pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:28.90pt;padding:0pt;">
					<p style="margin:0pt 1.6pt 0pt 10pt;line-height:100%;text-indent: -10pt;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-size:10pt;">By:</font></p>
				</td>
				<td valign="bottom" style="width:07.45pt;padding:0pt;">
					<p style="margin:0pt 1.6pt 0pt 0pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:198.00pt;padding:0pt;">
					<p style="margin:0pt 1.6pt 0pt 0pt;border-bottom:1pt solid #000000 ;line-height:100%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-size:10pt;">/s/ Brian B. Dow</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:28.90pt;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:07.45pt;padding:0pt;">
					<p style="margin:0pt 1.6pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 7pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:198.00pt;padding:0pt;">
					<p style="margin:0pt 1.6pt 0pt 0pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 7pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:7.5pt;">Brian B. Dow</font></p>
					<p style="margin:0pt 1.6pt 0pt 0pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 7pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:7.5pt;">Senior Vice President and Chief Financial Officer</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt 36pt;line-height:100%;text-indent:24.5pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 36pt;line-height:100%;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 36pt;line-height:100%;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-size:10pt;">Date:&nbsp; January 27, 2017</font>
		</p>
		<p style="margin:9pt 36pt 0pt 45pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:11.25pt 36pt 0pt;font-family:Calibri;line-height:107.92%;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&#xFEFF;</font>
		</p>
		<p><font size="1"> </font></p><hr size="3" style="color:#999999" width="100%" align="center"></hr>
	</div></body>
</html>
[{"type": "8-K", "sequence": "1", "filename": "plse-20170127x8k.htm", "description": "8-K", "secsgml_size_bytes": 33741}]
{"company-data": {"conformed-name": "Pulse Biosciences, Inc.", "cik": "0001625101", "assigned-sic": "3841", "irs-number": "000000000", "state-of-incorporation": "NV", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-37744", "film-number": "17553597"}, "business-address": {"street1": "849 MITTEN ROAD", "street2": "SUITE 104", "city": "BURLINGAME", "state": "CA", "zip": "90401", "phone": "650-697-3939"}, "mail-address": {"street1": "849 MITTEN ROAD", "street2": "SUITE 104", "city": "BURLINGAME", "state": "CA", "zip": "90401"}, "former-company": {"former-conformed-name": "Electroblate, Inc.", "date-changed": "20141113"}}
8K 2017-01-27
﻿
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
January 25, 2017
Pulse Biosciences, Inc.
(Exact name of registrant as specified in its charter)
﻿
Nevada
001-37744
46-5696597
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
849 Mitten Road, Suite 104
Burlingame, California 94010
(Address of principal executive offices, including zip code)
(650) 697-3939
(Registrant's telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2):
﻿
﻿
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
﻿
﻿
﻿
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
﻿
﻿
﻿
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
﻿
﻿
﻿
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 1.01 Entry into a Material Definitive Agreement.
On January 25, 2017, Pulse Biosciences, Inc. (the "Company") entered into a new lease agreement (the "Lease") by and between the Company and Hayward Point Eden I Limited Partnership, a Delaware limited liability company (the "Landlord"), for premises consisting of approximately fifteen thousand six hundred ninety-seven (15,697) rentable square feet located at 3955 Point Eden Way, Hayward, California (the "Premises").
The Premises will be used for the Company's corporate headquarters and principal operating facility. The term of the Lease is sixty-two (62) months, commencing on the date that is the earlier of (i) the date upon which the Company commences business in the Premises or (ii) the date upon which the Premises is "Ready for Occupancy" as defined in the lease.  Base monthly rent shall be abated for the first two (2) months of the Lease term and thereafter will be $42,400 per month during the first year of the Lease term, with specified annual increases thereafter until reaching approximately $50,300 per month during the last two (2) months of the Lease term. The Company is required to pay a refundable security deposit of approximately $101,000.   The Landlord is obligated to provide the Company with improvement allowances in the amount of approximately $135.00 per rentable square foot of the Premises, which may be applied towards the costs of construction of the initial improvements in the Premises. The Company will be responsible for any such improvement costs in excess of the foregoing allowances.  The Company may also be required to reimburse Landlord for certain expenses during the Lease term.
The Company has the right to extend the Lease term by five (5) years upon written notice not more than twelve (12) months nor less than nine (9) months prior to the expiration of the original Lease term, with monthly payments equal to the "Fair Rental Value" as defined in the Lease.  The Company has also reserved the right to terminate the Lease if the Landlord is unable to deliver the facility to the Company by December 1, 2017.
﻿
﻿
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
﻿
Pulse Biosciences, Inc.
By:
/s/ Brian B. Dow
Brian B. Dow
Senior Vice President and Chief Financial Officer
Date:  January 27, 2017
﻿